Source: FINANZNACHRICHTEN.DE

Spiracur: Spiracur Expands Global Reach With the Release of New International Clinical Data and the Introduction of the SNaP Plus Therapy System / New Clinical Data Reaffirms Better Wound Healing, Cost Savings and Improved Patient Quality of Life With Spiracur's S

SUNNYVALE, CA -- (Marketwired) -- 06/02/15 -- Spiracur today announced that results from new European clinical studies of its SNaP® Therapy System confirm the positive impact of its device on woun...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Chris Fashek's photo - President & CEO of Spiracur

President & CEO

Chris Fashek

CEO Approval Rating

74/100

Read more